Meningioma causing gabapentin-responsive secondary SUNCT syndrome.
Short-lasting unilateral neuralgiform headache with conjunctival injection and tearing (SUNCT) is one of the rarest and most serious headache disorders. Cases of symptomatic SUNCT syndromes are reported, which demonstrate that brain imaging is very important for diagnosis. In this study, we describe the first case of secondary SUNCT syndrome caused by a meningioma. So far, a clearly effective therapy for SUNCT syndrome has not been known. In this case, however, SUNCT was completely responsive to gabapentin. This underlines that this drug is worthy of being considered as a potential therapeutic option in the treatment of SUNCT syndrome.
Kutschenko
Anna
A
Department of Clinical Neurophysiology, University Medical Centre Göttingen, Robert-Koch-Strasse 40, 37099 Göttingen, Germany anna.kutschenko@med.uni-goettingen.de
Liebetanz
David
D
D000369:Aged, 80 and over; D000588:Amines / Q000627:therapeutic use*; D000700:Analgesics / Q000627:therapeutic use*; D003509:Cyclohexanecarboxylic Acids / Q000627:therapeutic use*; D005260:Female; D000077206:Gabapentin; D006801:Humans; D008577:Meningeal Neoplasms / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D008579:Meningioma / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D050798:SUNCT Syndrome / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D005680:gamma-Aminobutyric Acid / Q000627:therapeutic use*
D000588:Amines; D000700:Analgesics; D003509:Cyclohexanecarboxylic Acids; D005680:gamma-Aminobutyric Acid; D000077206:Gabapentin